APA

Rotondi M., Romagnani P., Brozzetti A., Santeusanio F., Serio M. & Falorni A. (20040412). to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. : Diabetologia.

Chicago

Rotondi M, Romagnani P, Brozzetti A, Santeusanio F, Serio M and Falorni A. 20040412. to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. : Diabetologia.

Harvard

Rotondi M., Romagnani P., Brozzetti A., Santeusanio F., Serio M. and Falorni A. (20040412). to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. : Diabetologia.

MLA

Rotondi M, Romagnani P, Brozzetti A, Santeusanio F, Serio M and Falorni A. to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. : Diabetologia. 20040412.